HR 1026
117th Congress
House
Crime and Law Enforcement
Administrative law and regulatory procedures
Consumer affairs
Criminal justice information and records
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Health information and medical records
Prescription drugs
LABEL Opioids Act
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 28, 2021
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Feb 12, 2021
Referred to the Subcommittee on Health.
Feb 11, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 11, 2021
Introduced in House
Plain-English summary
Lessening Addiction By Enhancing Labeling Opioids Act of 2021 or the LABEL Opioids Act
This bill requires prescription opioids to contain a warning label specifying that the opioids may cause dependence, addiction, and overdose. A registrant (e.g., a pharmacist) who dispenses an opioid in violation of the labeling requirement is subject to penalties.
What's happening now
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Committees of jurisdiction
4